Keros Therapeutics Inc at Goldman Sachs Healthcare Conference Transcript
All right. Good afternoon, everyone. Thanks for joining us here at the Goldman Sachs Global Healthcare Conference, including to all the people who are joining us online, and we have the cocktail slot, meaning we're preventing everyone from drinking our cocktail. So we're going to keep this interesting, I hope. And it's great to see you today.
Questions & Answers
So maybe just first, Jas, we could talk about kind of a little bit of background on the company and what you think about as the core competencies of Keros, particularly as you embark on a new development program here?
Yeah. I think, first of all, we are a company that's been focused on TGF-beta biology. And it's a complex area of biology, but we've been working in it through various iterations for the last 25-plus years. So I think we have a deep understanding that is unique to us in terms of what's druggable and what are the indications that you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
